RGB-286638
| Title | Journal |
|---|---|
| Phase I study of RGB-286638, a novel, multitargeted cyclin-dependent kinase inhibitor in patients with solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20140915 |
| Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs. | Leukemia 20131201 |
| Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry. | Journal of pharmaceutical and biomedical analysis 20091205 |